Request for Covid-19 Impact Assessment of this Report
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Platform market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Infectious Disease Vaccines
Cancer Vaccines
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Infectious Disease
Cancer
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Arcturus Therapeutic
Argos Therapeutics
BioNTec
CureVac
Etherna
Ethris
GlaxoSmithKline
Pfizer
Translate Bio
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global mRNA Platform Market Size 2016-2026
2.1.2 mRNA Platform Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 mRNA Platform Segment by Type
2.2.1 Infectious Disease Vaccines
2.2.2 Infectious Disease Vaccines
2.3 mRNA Platform Market Size by Type
2.3.1 Global mRNA Platform Market Size CAGR by Type
2.3.2 Global mRNA Platform Market Size Market Share by Type (2016-2021)
2.4 mRNA Platform Segment by Application
2.4.1 Infectious Disease
2.4.2 Cancer
2.5 mRNA Platform Market Size by Application
2.5.1 Global mRNA Platform Market Size CAGR by Application
2.5.2 Global mRNA Platform Market Size Market Share by Application (2016-2021)
3 mRNA Platform Market Size by Players
3.1 mRNA Platform Market Size Market Share by Players
3.1.1 Global mRNA Platform Revenue by Players (2019-2021E)
3.1.2 Global mRNA Platform Revenue Market Share by Players (2019-2021E)
3.2 Global mRNA Platform Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 mRNA Platform by Regions
4.1 mRNA Platform Market Size by Regions (2016-2021)
4.2 Americas mRNA Platform Market Size Growth (2016-2021)
4.3 APAC mRNA Platform Market Size Growth (2016-2021)
4.4 Europe mRNA Platform Market Size Growth (2016-2021)
4.5 Middle East & Africa mRNA Platform Market Size Growth (2016-2021)
5 Americas
5.1 Americas mRNA Platform Market Size by Country (2016-2021)
5.2 Americas mRNA Platform Market Size by Type (2016-2021)
5.3 Americas mRNA Platform Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Platform Market Size by Region (2016-2021)
6.2 APAC mRNA Platform Market Size by Type (2016-2021)
6.3 APAC mRNA Platform Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe mRNA Platform by Country (2016-2021)
7.2 Europe mRNA Platform Market Size by Type (2016-2021)
7.3 Europe mRNA Platform Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa mRNA Platform by Region (2016-2021)
8.2 Middle East & Africa mRNA Platform Market Size by Type (2016-2021)
8.3 Middle East & Africa mRNA Platform Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global mRNA Platform Market Forecast
10.1 Global mRNA Platform Forecast by Regions (2021-2026)
10.1.1 Global mRNA Platform Forecast by Regions (2021-2026)
10.1.2 Americas mRNA Platform Forecast
10.1.3 APAC mRNA Platform Forecast
10.1.4 Europe mRNA Platform Forecast
10.1.5 Middle East & Africa mRNA Platform Forecast
10.2 Americas mRNA Platform Forecast by Countries (2021-2026)
10.2.1 United States mRNA Platform Market Forecast
10.2.2 Canada mRNA Platform Market Forecast
10.2.3 Mexico mRNA Platform Market Forecast
10.2.4 Brazil mRNA Platform Market Forecast
10.3 APAC mRNA Platform Forecast by Region (2021-2026)
10.3.1 China mRNA Platform Market Forecast
10.3.2 Japan mRNA Platform Market Forecast
10.3.3 Korea mRNA Platform Market Forecast
10.3.4 Southeast Asia mRNA Platform Market Forecast
10.3.5 India mRNA Platform Market Forecast
10.3.6 Australia mRNA Platform Market Forecast
10.4 Europe mRNA Platform Forecast by Country (2021-2026)
10.4.1 Germany mRNA Platform Market Forecast
10.4.2 France mRNA Platform Market Forecast
10.4.3 UK mRNA Platform Market Forecast
10.4.4 Italy mRNA Platform Market Forecast
10.4.5 Russia mRNA Platform Market Forecast
10.5 Middle East & Africa mRNA Platform Forecast by Region (2021-2026)
10.5.1 Egypt mRNA Platform Market Forecast
10.5.2 South Africa mRNA Platform Market Forecast
10.5.3 Israel mRNA Platform Market Forecast
10.5.4 Turkey mRNA Platform Market Forecast
10.5.5 GCC Countries mRNA Platform Market Forecast
10.6 Global mRNA Platform Forecast by Type (2021-2026)
10.7 Global mRNA Platform Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 Arcturus Therapeutic
11.1.1 Arcturus Therapeutic Company Information
11.1.2 Arcturus Therapeutic mRNA Platform Product Offered
11.1.3 Arcturus Therapeutic mRNA Platform Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Arcturus Therapeutic Main Business Overview
11.1.5 Arcturus Therapeutic Latest Developments
11.2 Argos Therapeutics
11.2.1 Argos Therapeutics Company Information
11.2.2 Argos Therapeutics mRNA Platform Product Offered
11.2.3 Argos Therapeutics mRNA Platform Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Argos Therapeutics Main Business Overview
11.2.5 Argos Therapeutics Latest Developments
11.3 BioNTec
11.3.1 BioNTec Company Information
11.3.2 BioNTec mRNA Platform Product Offered
11.3.3 BioNTec mRNA Platform Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 BioNTec Main Business Overview
11.3.5 BioNTec Latest Developments
11.4 CureVac
11.4.1 CureVac Company Information
11.4.2 CureVac mRNA Platform Product Offered
11.4.3 CureVac mRNA Platform Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 CureVac Main Business Overview
11.4.5 CureVac Latest Developments
11.5 Etherna
11.5.1 Etherna Company Information
11.5.2 Etherna mRNA Platform Product Offered
11.5.3 Etherna mRNA Platform Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Etherna Main Business Overview
11.5.5 Etherna Latest Developments
11.6 Ethris
11.6.1 Ethris Company Information
11.6.2 Ethris mRNA Platform Product Offered
11.6.3 Ethris mRNA Platform Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Ethris Main Business Overview
11.6.5 Ethris Latest Developments
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Information
11.7.2 GlaxoSmithKline mRNA Platform Product Offered
11.7.3 GlaxoSmithKline mRNA Platform Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 GlaxoSmithKline Main Business Overview
11.7.5 GlaxoSmithKline Latest Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer mRNA Platform Product Offered
11.8.3 Pfizer mRNA Platform Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Pfizer Main Business Overview
11.8.5 Pfizer Latest Developments
11.9 Translate Bio
11.9.1 Translate Bio Company Information
11.9.2 Translate Bio mRNA Platform Product Offered
11.9.3 Translate Bio mRNA Platform Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Translate Bio Main Business Overview
11.9.5 Translate Bio Latest Developments
12 Research Findings and Conclusion
Table 1. mRNA Platform Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Infectious Disease Vaccines
Table 3. Major Players of Cancer Vaccines
Table 4. mRNA Platform Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 5. Global mRNA Platform Market Size by Type (2016-2021) & ($ Millions)
Table 6. Global mRNA Platform Market Size Market Share by Type (2016-2021)
Table 7. mRNA Platform Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 8. Global mRNA Platform Market Size by Application (2016-2021) & ($ Millions)
Table 9. Global mRNA Platform Market Size Market Share by Application (2016-2021)
Table 10. Global mRNA Platform Revenue by Players (2019-2021E) & ($ Millions)
Table 11. Global mRNA Platform Revenue Market Share by Players (2019-2021E)
Table 12. mRNA Platform Key Players Head office and Products Offered
Table 13. mRNA Platform Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global mRNA Platform Market Size by Regions 2016-2021 & ($ Millions)
Table 17. Global mRNA Platform Market Size Market Share by Regions 2016-2021
Table 18. Americas mRNA Platform Market Size by Country (2016-2021) & ($ Millions)
Table 19. Americas mRNA Platform Market Size Market Share by Country (2016-2021)
Table 20. Americas mRNA Platform Market Size by Type (2016-2021) & ($ Millions)
Table 21. Americas mRNA Platform Market Size Market Share by Type (2016-2021)
Table 22. Americas mRNA Platform Market Size by Application (2016-2021) & ($ Millions)
Table 23. Americas mRNA Platform Market Size Market Share by Application (2016-2021)
Table 24. APAC mRNA Platform Market Size by Region (2016-2021) & ($ Millions)
Table 25. APAC mRNA Platform Market Size Market Share by Region (2016-2021)
Table 26. APAC mRNA Platform Market Size by Type (2016-2021) & ($ Millions)
Table 27. APAC mRNA Platform Market Size Market Share by Type (2016-2021)
Table 28. APAC mRNA Platform Market Size by Application (2016-2021) & ($ Millions)
Table 29. APAC mRNA Platform Market Size Market Share by Application (2016-2021)
Table 30. Europe mRNA Platform Market Size by Country (2016-2021) & ($ Millions)
Table 31. Europe mRNA Platform Market Size Market Share by Country (2016-2021)
Table 32. Europe mRNA Platform Market Size by Type (2016-2021) & ($ Millions)
Table 33. Europe mRNA Platform Market Size Market Share by Type (2016-2021)
Table 34. Europe mRNA Platform Market Size by Application (2016-2021) & ($ Millions)
Table 35. Europe mRNA Platform Market Size Market Share by Application (2016-2021)
Table 36. Middle East & Africa mRNA Platform Market Size by Region (2016-2021) & ($ Millions)
Table 37. Middle East & Africa mRNA Platform Market Size Market Share by Region (2016-2021)
Table 38. Middle East & Africa mRNA Platform Market Size by Type (2016-2021) & ($ Millions)
Table 39. Middle East & Africa mRNA Platform Market Size Market Share by Type (2016-2021)
Table 40. Middle East & Africa mRNA Platform Market Size by Application (2016-2021) & ($ Millions)
Table 41. Middle East & Africa mRNA Platform Market Size Market Share by Application (2016-2021)
Table 42. Key and Potential Regions of mRNA Platform
Table 43. Key Application and Potential Industries of mRNA Platform
Table 44. Key Challenges of mRNA Platform
Table 45. Key Trends of mRNA Platform
Table 46. Global mRNA Platform Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 47. Global mRNA Platform Market Size Market Share Forecast by Regions (2021-2026)
Table 48. Global mRNA Platform Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 49. Global mRNA Platform Market Size Market Share Forecast by Type (2021-2026)
Table 50. Global mRNA Platform Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 51. Global mRNA Platform Market Size Market Share Forecast by Application (2021-2026)
Table 52. Arcturus Therapeutic Details, Company Type, mRNA Platform Area Served and Its Competitors
Table 53. Arcturus Therapeutic mRNA Platform Product Offered
Table 54. Arcturus Therapeutic mRNA Platform Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 55. Arcturus Therapeutic Main Business
Table 56. Arcturus Therapeutic Latest Developments
Table 57. Argos Therapeutics Details, Company Type, mRNA Platform Area Served and Its Competitors
Table 58. Argos Therapeutics mRNA Platform Product Offered
Table 59. Argos Therapeutics Main Business
Table 60. Argos Therapeutics mRNA Platform Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 61. Argos Therapeutics Latest Developments
Table 62. BioNTec Details, Company Type, mRNA Platform Area Served and Its Competitors
Table 63. BioNTec mRNA Platform Product Offered
Table 64. BioNTec Main Business
Table 65. BioNTec mRNA Platform Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 66. BioNTec Latest Developments
Table 67. CureVac Details, Company Type, mRNA Platform Area Served and Its Competitors
Table 68. CureVac mRNA Platform Product Offered
Table 69. CureVac Main Business
Table 70. CureVac mRNA Platform Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 71. CureVac Latest Developments
Table 72. Etherna Details, Company Type, mRNA Platform Area Served and Its Competitors
Table 73. Etherna mRNA Platform Product Offered
Table 74. Etherna Main Business
Table 75. Etherna mRNA Platform Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 76. Etherna Latest Developments
Table 77. Ethris Details, Company Type, mRNA Platform Area Served and Its Competitors
Table 78. Ethris mRNA Platform Product Offered
Table 79. Ethris Main Business
Table 80. Ethris mRNA Platform Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 81. Ethris Latest Developments
Table 82. GlaxoSmithKline Details, Company Type, mRNA Platform Area Served and Its Competitors
Table 83. GlaxoSmithKline mRNA Platform Product Offered
Table 84. GlaxoSmithKline Main Business
Table 85. GlaxoSmithKline mRNA Platform Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 86. GlaxoSmithKline Latest Developments
Table 87. Pfizer Details, Company Type, mRNA Platform Area Served and Its Competitors
Table 88. Pfizer mRNA Platform Product Offered
Table 89. Pfizer Main Business
Table 90. Pfizer mRNA Platform Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 91. Pfizer Latest Developments
Table 92. Translate Bio Details, Company Type, mRNA Platform Area Served and Its Competitors
Table 93. Translate Bio mRNA Platform Product Offered
Table 94. Translate Bio Main Business
Table 95. Translate Bio mRNA Platform Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 96. Translate Bio Latest Developments
List of Figures
Figure 1. mRNA Platform Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global mRNA Platform Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global mRNA Platform Market Size Market Share by Type in 2020
Figure 7. mRNA Platform in Infectious Disease
Figure 8. Global mRNA Platform Market: Infectious Disease (2016-2021) & ($ Millions)
Figure 9. mRNA Platform in Cancer
Figure 10. Global mRNA Platform Market: Cancer (2016-2021) & ($ Millions)
Figure 11. Global mRNA Platform Market Size Market Share by Application in 2020
Figure 12. Global mRNA Platform Revenue Market Share by Player in 2020
Figure 13. Global mRNA Platform Market Size Market Share by Regions (2016-2021)
Figure 14. Americas mRNA Platform Market Size 2016-2021 ($ Millions)
Figure 15. APAC mRNA Platform Market Size 2016-2021 ($ Millions)
Figure 16. Europe mRNA Platform Market Size 2016-2021 ($ Millions)
Figure 17. Middle East & Africa mRNA Platform Market Size 2016-2021 ($ Millions)
Figure 18. Americas mRNA Platform Market Size Market Share by Country in 2020
Figure 19. Americas mRNA Platform Market Size Market Share by Type in 2020
Figure 20. Americas mRNA Platform Market Size Market Share by Application in 2020
Figure 21. United States mRNA Platform Market Size Growth 2016-2021 ($ Millions)
Figure 22. Canada mRNA Platform Market Size Growth 2016-2021 ($ Millions)
Figure 23. Mexico mRNA Platform Market Size Growth 2016-2021 ($ Millions)
Figure 24. APAC mRNA Platform Market Size Market Share by Regions in 2020
Figure 25. APAC mRNA Platform Market Size Market Share by Type in 2020
Figure 26. APAC mRNA Platform Market Size Market Share by Application in 2020
Figure 27. China mRNA Platform Market Size Growth 2016-2021 ($ Millions)
Figure 28. Japan mRNA Platform Market Size Growth 2016-2021 ($ Millions)
Figure 29. Korea mRNA Platform Market Size Growth 2016-2021 ($ Millions)
Figure 30. Southeast Asia mRNA Platform Market Size Growth 2016-2021 ($ Millions)
Figure 31. India mRNA Platform Market Size Growth 2016-2021 ($ Millions)
Figure 32. Australia mRNA Platform Market Size Growth 2016-2021 ($ Millions)
Figure 33. Europe mRNA Platform Market Size Market Share by Country in 2020
Figure 34. Europe mRNA Platform Market Size Market Share by Type in 2020
Figure 35. Europe mRNA Platform Market Size Market Share by Application in 2020
Figure 36. Germany mRNA Platform Market Size Growth 2016-2021 ($ Millions)
Figure 37. France mRNA Platform Market Size Growth 2016-2021 ($ Millions)
Figure 38. UK mRNA Platform Market Size Growth 2016-2021 ($ Millions)
Figure 39. Italy mRNA Platform Market Size Growth 2016-2021 ($ Millions)
Figure 40. Russia mRNA Platform Market Size Growth 2016-2021 ($ Millions)
Figure 41. Middle East & Africa mRNA Platform Market Size Market Share by Region in 2020
Figure 42. Middle East & Africa mRNA Platform Market Size Market Share by Type in 2020
Figure 43. Middle East & Africa mRNA Platform Market Size Market Share by Application in 2020
Figure 44. Egypt mRNA Platform Market Size Growth 2016-2021 ($ Millions)
Figure 45. South Africa mRNA Platform Market Size Growth 2016-2021 ($ Millions)
Figure 46. Israel mRNA Platform Market Size Growth 2016-2021 ($ Millions)
Figure 47. Turkey mRNA Platform Market Size Growth 2016-2021 ($ Millions)
Figure 48. GCC Country mRNA Platform Market Size Growth 2016-2021 ($ Millions)
Figure 49. Americas mRNA Platform Market Size 2021-2026 ($ Millions)
Figure 50. APAC mRNA Platform Market Size 2021-2026 ($ Millions)
Figure 51. Europe mRNA Platform Market Size 2021-2026 ($ Millions)
Figure 52. Middle East & Africa mRNA Platform Market Size 2021-2026 ($ Millions)
Figure 53. United States mRNA Platform Market Size 2021-2026 ($ Millions)
Figure 54. Canada mRNA Platform Market Size 2021-2026 ($ Millions)
Figure 55. Mexico mRNA Platform Market Size 2021-2026 ($ Millions)
Figure 56. Brazil mRNA Platform Market Size 2021-2026 ($ Millions)
Figure 57. China mRNA Platform Market Size 2021-2026 ($ Millions)
Figure 58. Japan mRNA Platform Market Size 2021-2026 ($ Millions)
Figure 59. Korea mRNA Platform Market Size 2021-2026 ($ Millions)
Figure 60. Southeast Asia mRNA Platform Market Size 2021-2026 ($ Millions)
Figure 61. India mRNA Platform Market Size 2021-2026 ($ Millions)
Figure 62. Australia mRNA Platform Market Size 2021-2026 ($ Millions)
Figure 63. Germany mRNA Platform Market Size 2021-2026 ($ Millions)
Figure 64. France mRNA Platform Market Size 2021-2026 ($ Millions)
Figure 65. UK mRNA Platform Market Size 2021-2026 ($ Millions)
Figure 66. Italy mRNA Platform Market Size 2021-2026 ($ Millions)
Figure 67. Russia mRNA Platform Market Size 2021-2026 ($ Millions)
Figure 68. Spain mRNA Platform Market Size 2021-2026 ($ Millions)
Figure 69. Egypt mRNA Platform Market Size 2021-2026 ($ Millions)
Figure 70. South Africa mRNA Platform Market Size 2021-2026 ($ Millions)
Figure 71. Israel mRNA Platform Market Size 2021-2026 ($ Millions)
Figure 72. Turkey mRNA Platform Market Size 2021-2026 ($ Millions)
Figure 73. GCC Country mRNA Platform Market Size 2021-2026 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...